Quetiapine Fumarate Tablet, Film Coated, Extended Release
Product Images NDC 65862-877

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 65862-877). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 Kaplan-meier Curves Of Time To Schizophrenic Relapse (study 3) (Quetiapine Fig1)

The figure shows Kaplan-Meier curves indicating the time it takes for patients with schizophrenia to experience relapse, obtained from study 3. The x-axis shows the time in months, and the y-axis shows the proportion of patients with relapse. The results include the placebo (PLA) and quetiapine (QTP) treatments, with extended-release (ER) quetiapine also being included. These results are from an interim analysis.*

FDA Label Image

Figure 3 (Quetiapine Fig2)

This is a figure depicting the Kaplan-Meier Curves demonstrating the time to recurrence of a mood event in Study 9. The y-axis shows the proportion of patients experiencing a relapse as a percentage, and the x-axis shows the time in weeks. No further information or details are provided.*

FDA Label Image

Figure 3 (Quetiapine Fig3)

This figure shows the Kaplan-Meier curves representing the time to recurrence of a mood event in Study 10. The x-axis shows the time in weeks, and the y-axis represents the proportion of patients with relapse. The percentage value is not provided, indicated by a series of unrelated characters at the bottom of the image.*

FDA Label Image

Package Label-principal Display Panel (50 mg (60 Tablet Bottle))

This is a medication called Quetiapine Extended-Release, in tablet form, containing 58 mg of quetiapine fumarate, which is equivalent to 50mg quetiapine. It is to be taken once daily and must be swallowed whole. This medication should be kept out of reach of children and stored at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. It is distributed by Aurobindo Pharma USA, Inc. A medication guide is provided separately to each patient.*

FDA Label Image

Package Label-principal Display Panel (150 mg (60 Tablet Bottle))

This is a prescription drug called Quetiapine Extended-Release. It comes in a film-coated tablet form that contains 173mg of Quetiapine fumarate equivalent to 150mg Quetiapine USP. The recommended dosage is once daily, and it must be swallowed as a whole without chewing, splitting, or crushing. The medication guide provided separately to each patient by the pharmacist must be dispensed. This drug must be kept out of children's reach and stored at USP Controlled Room Temperature of 20° to 25°C (68° to 77°F). The manufacturer is Aurabindo Pharma USA, Inc, and the product is distributed in the US.*

FDA Label Image

Package Label-principal Display Panel (200 mg (60 Tablet Bottle))

FDA Label Image

Package Label-principal Display Panel (300 mg (60 Tablet Bottle))

FDA Label Image

Package Label-principal Display Panel (400 mg (60 Tablet Bottle))

FDA Label Image

Chemical Structure (Quetiapine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.